Skip to main content

IB Acquisition Corp.

IBACR
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001998781

No open-market purchases or sales by IB Acquisition Corp. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $660.9K in total; no superinvestor holds it.

Other share classesIBAC

Q4 2025 vs. Q3 2025

How the institutions holding IB Acquisition Corp. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of IBACR: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders301290
Shares8.86M462.8K8.32M−85.9K (−1.0%)
Value$724.6K$38.7K$629.6K−$56.2K (−8.2%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (1)

Institutions that held IB Acquisition Corp. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to IBACR in Q4 2025
InstitutionSharesValue% of portfolio
Evercore Wealth Management, LLC19,576$1.53K0.00%

Sold out (1)

Institutions that held IB Acquisition Corp. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of IBACR in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Fifth Lane Capital, LP100,000$8.00K

Not filed for Q4 2025 yet (1)

Institutions that held IB Acquisition Corp. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBACR in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Atw Spac Management LLC462,793$38.7K